BodyTel Signs Distribution Agreement With Diabetes Supplies
BodyTel Scientific, through its wholly owned subsidiary BodyTel Europe, has entered into an exclusive distribution agreement with New Zealand-based Diabetes Supplies.
BodyTel’s new partner, Diabetes Supplies, intends to begin offering BodyTel’s blood glucose monitoring and diabetes management system, GlucoTel, in New Zealand.
Pursuant to the terms of the distribution agreement, BodyTel granted Diabetes Supplies (DSL) the right to exclusively market the GlucoTel in the territory for a term of one year. Diabetes Supplies is also responsible for all distribution, compliance and marketing costs relating to the sale of the products in the territory.
Walter Stahl, CEO of Diabetes Supplies, said: “DSL has a tremendous reach in the New Zealand diabetes community, extending to patients and caregivers. We are delighted and excited to begin distributing the GlucoTel system in New Zealand, which we believe represents the future of glucose testing globally.”